ישראל - עברית - Ministry of Health

teva israel ltd - paliperidone palmitate - תרחיף להזרקה - שחרור נרחב - paliperidone palmitate 100 mg / 1 ml - paliperidone

ישראל - עברית - Ministry of Health

teva israel ltd - paliperidone as palmitate - תרחיף להזרקה - שחרור נרחב - paliperidone as palmitate 100 mg / 1 ml - paliperidone

ישראל - עברית - Ministry of Health

teva israel ltd - paliperidone as palmitate - תרחיף להזרקה - שחרור נרחב - paliperidone as palmitate 100 mg / 1 ml - paliperidone

ישראל - עברית - Ministry of Health

teva israel ltd - paliperidone palmitate - תרחיף להזרקה - שחרור נרחב - paliperidone palmitate 100 mg / 1 ml - paliperidone

ישראל - עברית - Ministry of Health

teva israel ltd - paliperidone as palmitate - תרחיף להזרקה - שחרור נרחב - paliperidone as palmitate 100 mg / 1 ml - paliperidone

ישראל - עברית - Ministry of Health

teva israel ltd - risperidone - אבקה וממס להכנת תרחיף בשחרור ממושך להזרקה - risperidone 25 mg/vial - risperidone

ישראל - עברית - Ministry of Health

teva israel ltd - risperidone - אבקה וממס להכנת תרחיף בשחרור ממושך להזרקה - risperidone 37.5 mg/vial - risperidone

ישראל - עברית - Ministry of Health

teva israel ltd - risperidone - אבקה וממס להכנת תרחיף בשחרור ממושך להזרקה - risperidone 50 mg/vial - risperidone

ישראל - עברית - Ministry of Health

teva israel ltd - clopidogrel as bisulfate - טבליה - clopidogrel as bisulfate 75 mg - clopidogrel - clopidogrel - clopidogrel is indicated for the prevention of atherothrombotic events as follows : * recent mi recent stroke or established peripheral arterial disease : - patients suffering from myocardial infarction (from a few days until less than 35 days ) - ischaemic stroke ( from 7 days until less than 6 months) or established peripheral arterial disease. - for patients with a history of recent myocardial infarction (mi) recent stroke or established peripheral arterial disease - clopidogrel has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not) new mi (fatal or not) and other vascular death. * acute coronary syndrome: - for patients with acute coronary syndrome [non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave mi) or st segment elevation acute myocardial infarction ] in combination with asa in medically treated patients eligible for thrombolytic therapy and those who are to be managed with percutaneous coronary intervention (with or without stent) or

ישראל - עברית - Ministry of Health

teva israel ltd - diltiazem hydrochloride - טבליה - diltiazem hydrochloride 30 mg - diltiazem - diltiazem - calcium channel blocker for the treatment of angina pectoris.